Progression clinical trials

Explore recruiting progression clinical trials.

Recruiting progression studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Progression trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Pragmatic management of progressive disease in idiopathic pulmonary fibrosis: a randomized trial. PROGRESSION-IPF

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled Study of Intravenously Administered ALE.F02 to Evaluate the Safety, Tolerability, Pharmacokinetics, and Renal Sparing in Antineutrophil Cytoplasmic Antibody Associated Vasculitis With Rapidly Progressive Glomerulonephritis

Czechia, Germany, Italy, Spain, Denmark, France +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

LADIGAGA - Long–term Analysis of DImethyl fumarate, to slow the Growth of Areas of Geographic Atrophy

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Vonafexor fixed dose-escalation safety and proof-of-concept study in patients with at risk of progression Alport syndrome

Spain, France, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

EORTC 2227-BTG: Lomustine with or without reirradiation for first progression of glioblastoma: a randomized phase III study (LEGATO)

Italy, France, Norway, Spain, Belgium, Austria +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

IMMUNOGAST: An umbrella phase 2 trial to assess personalized targeted IMMUNOtherapy-based regimens in recurrent advanced/metastatic GASTric adenocarcinoma patients

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Progression trials by city

Progression in Toronto Progression in Vancouver Progression in Montreal Progression in Calgary Progression in Edmonton Progression in Ottawa Progression in Winnipeg Progression in Quebec City Progression in Hamilton Progression in Kitchener Progression in London Progression in Halifax Progression in New York Progression in Los Angeles Progression in Chicago Progression in Houston

Progression clinical trials

Recruiting progression studies right now

Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression

Aerobic Fitness or Muscle Mass Training to Improve Colorectal Cancer Outcome

A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression

De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Children's Viewing Behavior

Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer

Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy

Also recruiting in Europe

Pragmatic management of progressive disease in idiopathic pulmonary fibrosis: a randomized trial. PROGRESSION-IPF

A Randomized, Double-Blind, Placebo-Controlled Study of Intravenously Administered ALE.F02 to Evaluate the Safety, Tolerability, Pharmacokinetics, and Renal Sparing in Antineutrophil Cytoplasmic Antibody Associated Vasculitis With Rapidly Progressive Glomerulonephritis

LADIGAGA - Long–term Analysis of DImethyl fumarate, to slow the Growth of Areas of Geographic Atrophy

Vonafexor fixed dose-escalation safety and proof-of-concept study in patients with at risk of progression Alport syndrome

EORTC 2227-BTG: Lomustine with or without reirradiation for first progression of glioblastoma: a randomized phase III study (LEGATO)

IMMUNOGAST: An umbrella phase 2 trial to assess personalized targeted IMMUNOtherapy-based regimens in recurrent advanced/metastatic GASTric adenocarcinoma patients

Progression trials by city

Other conditions